2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

International Trends in Organ Donation

147.3 - Validation of the Kidney Donor Risk Index (KDRI) Score in a UK Single Centre DCD Cohort

Presenter: James, Pine, Leeds,
Authors: Pine J., Goldsmith P., Ridgway D., Brady K., Pollard S., Attia M., Ahmad N., Menon K.

VALIDATION OF THE KIDNEY DONOR RISK INDEX (KDRI) SCORE IN A UK SINGLE CENTRE DCD COHORT

INTERNATIONAL TRENDS IN ORGAN DONATION

J.K. Pine, P.J. Goldsmith, D.M. Ridgway, K. Brady, S. Pollard, M. Attia, N. Ahmad, K.V. Menon
Organ Transplantation, St James's University Hospital, Leeds/UNITED KINGDOM

Body: Introduction. Donation after cardiac death (DCD) increase the number of available grafts by expanding the donor pool beyond the conventional brainstem death donors (DBDs). The use of these marginal grafts would be enhanced by being able to estimate graft outcome based on patient factors. The Kidney Donor Risk Index (KDRI) is one method proposed to allow accurate assessment of the relative risk of graft failure based on donor and transplant variables, independent of the recipient.1 We attempt to validate this score in a cohort of DCD grafts transplanted at St James’s University Hospital, Leeds, in order to determine its usefulness when assessing these marginal grafts. Method. Data required to produce a KDRI score was obtained from an existing database. The variables required were: donor age, donor ethnicity, donor hypertension, donor diabetes, donor serum creatinine, donor cause of death, donor height and weight, DCD, donor hepatitis C status, number of B mismatches, number of DR mismatches, cold ischemic time and whether the procedure was an en-bloc or double renal transplant. This data was then used to produce a KDRI score as described in Rao et al (2009)1. Results. Between April 2002 and December 2009, 201 transplants utilising DCD grafts were performed at St James’s University Hospital, Leeds. Of these a complete set of variables allowing KDRI calculation was available in 184. The cohort was then divided into those with a KDRI of <1 (n=48), those with a KDRI of 1-1.5 (n=95), and those with a KDRI of >1.5 (n=41). Survival analysis revealed that both patient and graft survival was significantly reduced in the KDRI >1.5 group (p=0.04 & p=0.038) with estimated 5-year graft survival approaching 50%. A Kaplan-Meier curve for graft survival demonstrates the stratification of risk provided by the KDRI score (figure 1). Discussion. The use of DCD grafts in renal transplantation is an accepted method of expanding the donor pool. This study validates the use of the KDRI score in this cohort of patients. Graft survival for patients in the high DRI group is significantly different at 1 yr and continues to deteriorate thereafter. The KDRI is potentially a useful tool when assessing marginal DCD grafts. Figure 1. 1. Rao et al. A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk Index. Transplantation, 2009; 88(2):231-236.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada